Francis X Wilson

Title: Francis X Wilson: Innovator in Pharmaceutical Dosage Forms

Introduction

Francis X Wilson is a notable inventor based in Welwyn Garden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid tablet dosage forms.

Latest Patents

Wilson holds a patent for a solid tablet oral dosage form of ridinilazole. This invention relates to the compound 2,2'-di(pyridin-4-yl)-1H,1′H-5,5′-bibenzo[d]imidazole, which is also known by various names including 2,2′-di-4-pyridinyl-6,6′-bi-1H-benzimidazole. The patent encompasses pharmaceutically acceptable derivatives, salts, hydrates, solvates, complexes, bioisosteres, metabolites, or prodrugs of ridinilazole.

Career Highlights

Francis X Wilson is associated with Summit (Oxford) Limited, where he has been instrumental in advancing pharmaceutical innovations. His work focuses on improving the efficacy and delivery of medications through innovative dosage forms.

Collaborations

Wilson has collaborated with notable colleagues such as Laura Trespidi and Jean-Francois Carniaux, contributing to a dynamic research environment that fosters innovation in drug development.

Conclusion

Francis X Wilson's contributions to the pharmaceutical industry, particularly through his patent on ridinilazole, highlight his role as an innovator in the field. His work continues to impact the development of effective medication delivery systems.